Age-Dependent Hematologic Toxicity Profiles and Prognostic Serologic Markers in Postoperative Radiochemotherapy Treatment for Uterine Cervical Cancer

por Meixner, Eva, Hoeltgen, Line, Hoegen, Philipp, König, Laila, Arians, Nathalie, Michel, Laura L., Smetanay, Katharina, Fremd, Carlo, Schneeweiss, Andreas, Debus, Jürgen, Hörner-Rieber, Juliane
Publicado 2022

Prediction of local recurrence risk after neoadjuvant chemotherapy in patients with primary breast cancer: Clinical utility of the MD Anderson Prognostic Index

por Michel, Laura L., Sommer, Laura, González Silos, Rosa, Lorenzo Bermejo, Justo, von Au, Alexandra, Seitz, Julia, Hennigs, André, Smetanay, Katharina, Golatta, Michael, Heil, Jörg, Schütz, Florian, Sohn, Christof, Schneeweiss, Andreas, Marmé, Frederik
Publicado 2019

Palliative Radiotherapy for Symptomatic Locally Advanced Breast Cancer

por Hoeltgen, Line, Meixner, Eva, Hoegen, Philipp, Sandrini, Elisabetta, Weykamp, Fabian, Forster, Tobias, Vinsensia, Maria, Lang, Kristin, König, Laila, Arians, Nathalie, Fremd, Carlo, Michel, Laura L., Smetanay, Katharina, Schneeweiss, Andreas, Wallwiener, Markus, Debus, Jürgen, Hörner-Rieber, Juliane
Publicado 2023

Bevacizumab-based treatment as salvage therapy in patients with recurrent symptomatic brain metastases

por Berghoff, Anna Sophie, Breckwoldt, Michael Oliver, Riedemann, Lars, Karimian-Jazi, Kianush, Loew, Sarah, Schlieter, Franziska, Furtner, Julia, Cinci, Marc, Thomas, Michael, Strowitzki, Moritz J, Marmé, Frederik, Michel, Laura L, Schmidt, Thomas, Jäger, Dirk, Bendszus, Martin, Preusser, Matthias, Wick, Wolfgang, Winkler, Frank
Publicado 2020

Return of individual genomic research results within the PRAEGNANT multicenter registry study

por Huebner, Hanna, Ruebner, Matthias, Kurbacher, Christian, Hadji, Peyman, Hartkopf, Andreas D., Lux, Michael P., Huober, Jens, Uhrig, Sabrina, Taran, Florin-Andrei, Overkamp, Friedrich, Tesch, Hans, Häberle, Lothar, Lüftner, Diana, Wallwiener, Markus, Müller, Volkmar, Beckmann, Matthias W., Hein, Alexander, Belleville, Erik, Untch, Michael, Janni, Wolfgang, Fehm, Tanja N., Kolberg, Hans-Christian, Wallwiener, Diethelm, Brucker, Sara Y., Schneeweiss, Andreas, Ettl, Johannes, Fasching, Peter A., Michel, Laura L.
Publicado 2022

Progression-Free Survival and Overall Survival in Patients with Advanced HER2-Positive Breast Cancer Treated with Trastuzumab Emtansine (T-DM1) after Previous Treatment with Pertuz...

por Michel, Laura L., Hartkopf, Andreas D., Fasching, Peter A., Kolberg, Hans-Christian, Hadji, Peyman, Tesch, Hans, Häberle, Lothar, Ettl, Johannes, Lüftner, Diana, Wallwiener, Markus, Müller, Volkmar, Beckmann, Matthias W., Belleville, Erik, Volz, Bernhard, Huebner, Hanna, Wimberger, Pauline, Hielscher, Carsten, Mundhenke, Christoph, Kurbacher, Christian, Wuerstlein, Rachel, Untch, Michael, Overkamp, Friedrich, Huober, Jens, Janni, Wolfgang, Taran, Florin-Andrei, Lux, Michael P., Wallwiener, Diethelm, Brucker, Sara Y., Schneeweiss, Andreas, Fehm, Tanja N.
Publicado 2020

Implementation of CDK4/6 Inhibitors and its Influence on the Treatment Landscape of Advanced Breast Cancer Patients – Data from the Real-World Registry PRAEGNANT

por Engler, Tobias, Fasching, Peter A., Lüftner, Diana, Hartkopf, Andreas D., Müller, Volkmar, Kolberg, Hans-Christian, Hadji, Peyman, Tesch, Hans, Häberle, Lothar, Ettl, Johannes, Wallwiener, Markus, Beckmann, Matthias W., Hein, Alexander, Belleville, Erik, Uhrig, Sabrina, Wimberger, Pauline, Hielscher, Carsten, Kurbacher, Christian M., Wuerstlein, Rachel, Untch, Michael, Taran, Florin-Andrei, Enzinger, Hans-Martin, Krabisch, Petra, Welslau, Manfred, Maasberg, Michael, Hempel, Dirk, Lux, Michael P., Michel, Laura L., Janni, Wolfgang, Wallwiener, Diethelm, Brucker, Sara Y., Fehm, Tanja N., Schneeweiss, Andreas
Publicado 2022